Keyphrases
Cancer Patients
100%
In Cancer
100%
Thrombocytopenia
100%
Anticoagulant Treatment
100%
Antiplatelet Treatment
100%
Antithrombotic Therapy
66%
Atrial Fibrillation
33%
Platelets
33%
Anticoagulation
33%
Bleeding Risk
33%
Secondary Prevention
33%
Anticoagulant Therapy
33%
Stent Thrombosis
33%
Antiplatelet Therapy
33%
Venous Thromboembolism
33%
Arterial Thrombosis
33%
New Indication
33%
Medicine and Dentistry
Malignant Neoplasm
100%
Thrombocytopenia
100%
Antithrombotic
100%
Antithrombotic Therapy
100%
Anticoagulation
100%
Antiplatelet
100%
Venous Thromboembolism
50%
Platelet
50%
Secondary Prevention
50%
Thrombosis
50%
Atrial Fibrillation
50%
Artery Thrombosis
50%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Anticoagulant Agent
100%
Thrombocytopenia
100%
Antiplatelet
100%
Antithrombotic Therapy
66%
Venous Thromboembolism
33%
Thrombosis
33%
Atrial Fibrillation
33%
Artery Thrombosis
33%
INIS
patients
100%
cancer
100%
therapy
100%
anticoagulants
100%
risks
66%
thrombosis
66%